AT
ABBV icon

American Trust’s AbbVie ABBV Stock Holding History

American Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.32M Sell
19,853
-2,808
-12% -$623K 0.38% 36
2025
Q4 		$5.18M Sell
22,661
-1,125
-5% -$256K 0.44% 36
2025
Q3 		$5.51M Sell
23,786
-104
-0.4% -$21.2K 0.47% 35
2025
Q2 		$4.43M Buy
23,890
+6,421
+37% +$1.19M 0.42% 40
2025
Q1 		$3.66M Sell
17,469
-1,642
-9% -$319K 0.9% 30
2024
Q4 		$3.4M Buy
19,111
+12,420
+186% +$2.28M 0.26% 65
2024
Q3 		$1.32M Buy
6,691
+223
+3% +$41.6K 0.11% 86
2024
Q2 		$1.11M Sell
6,468
-698
-10% -$116K 0.09% 89
2024
Q1 		$1.3M Buy
7,166
+357
+5% +$61.5K 0.11% 90
2023
Q4 		$1.06M Buy
6,809
+328
+5% +$47.8K 0.08% 94
2023
Q3 		$966K Sell
6,481
-800
-11% -$117K 0.07% 100
2023
Q2 		$981K Sell
7,281
-215
-3% -$31.5K 0.07% 136
2023
Q1 		$1.19M Buy
7,496
+129
+2% +$19.7K 0.08% 123
2022
Q4 		$1.19M Buy
7,367
+401
+6% +$61.5K 0.11% 116
2022
Q3 		$935K Sell
6,966
-130
-2% -$18.7K 0.08% 127
2022
Q2 		$1.09M Sell
7,096
-452
-6% -$69.1K 0.09% 120
2022
Q1 		$1.22M Buy
7,548
+420
+6% +$61K 0.08% 131
2021
Q4 		$965K Buy
+7,128
New +$842K 0.07% 103

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Trust's ABBV Position: Q1 2026 in Review

American Trust reduced its AbbVie (ABBV) stake by 12% in Q1 2026, selling an estimated $623K and leaving 19,853 shares worth $4.32M. The position accounts for 0.38% of the portfolio, ranked #36.

American Trust first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.51M in Q3 2025. 4,083 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • American Trust held 19,853 shares of AbbVie worth $4.32M as of Q1 2026.
  • American Trust sold 2,808 AbbVie shares in Q1 2026, an estimated $623K.
  • AbbVie made up 0.38% of American Trust's portfolio in Q1 2026, its #36 holding.
  • American Trust first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • American Trust's AbbVie position peaked at $5.51M in Q3 2025.
  • 4,083 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.